A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer

Triple-negative breast cancer (TNBC) patients usually lead to poor prognosis and survival because of metastasis. The major sites for TNBC metastasis include the lungs, brain, liver, and bone. Long non-coding RNAs (lncRNAs) are non-protein-coding transcripts longer than 200 nucleotides and have been...

Full description

Saved in:
Bibliographic Details
Published inOncogene Vol. 37; no. 34; pp. 4662 - 4678
Main Authors Wang, Po-Shun, Chou, Cheng-Han, Lin, Cheng-Han, Yao, Yun-Chin, Cheng, Hui-Chuan, Li, Hao-Yi, Chuang, Yu-Chung, Yang, Chia-Ning, Ger, Luo-Ping, Chen, Yu-Chia, Lin, Forn-Chia, Shen, Tang-Long, Hsiao, Michael, Lu, Pei-Jung
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 01.08.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Triple-negative breast cancer (TNBC) patients usually lead to poor prognosis and survival because of metastasis. The major sites for TNBC metastasis include the lungs, brain, liver, and bone. Long non-coding RNAs (lncRNAs) are non-protein-coding transcripts longer than 200 nucleotides and have been reported as important regulators in BC metastasis. However, the underlying mechanisms for lncRNAs regulating TNBC metastasis are not fully understood. Here we found that linc-ZNF469-3 was highly expressed in lung-metastatic LM2-4175 TNBC cells and overexpression of linc-ZNF469-3 enhanced invasion ability and stemness properties in vitro and lung metastasis in vivo. Furthermore, we found linc-ZNF469-3 physically interacted with miR-574-5p and overexpression of miR-574-5p attenuated ZEB1 expression. Importantly, endogenous high expressions of linc-ZNF469-3 and ZEB1 were correlated with tumor recurrence in TNBC patients with lung metastasis. Taken together, our findings suggested that linc-ZNF469-3 promotes lung metastasis of TNBC through miR-574-5p-ZEB1 signaling axis and may be used as potential prognostic marker for TNBC patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0950-9232
1476-5594
DOI:10.1038/s41388-018-0293-1